| Drug Name: | Methyltestosterone (58-18-4) |
|---|---|
| PubChem ID: | 6010 |
| SMILES: | C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C)O)C |
| InchiKey: | GCKMFJBGXUYNAG-HLXURNFRSA-N |
| Therapeutic Category: | Anabolic Agents, Antineoplastic Agents, Hormones |
| Molecular Weight (dalton) | : | 302.458 |
| LogP | : | 4.2693 |
| Ring Count | : | 0 |
| Hydrogen Bond Acceptor Count | : | 2 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 37.3 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Dangerous Side Effects | Cytochrome P450 2B6 (P20813) | Estratest inhibits CYP2B6 activity@ as a result it increases the level of mephenytoin in blood and causes dangerous side effects [ ADR Type 4 ] | Inhibition of cytochrome P450 2B6 activity by hormone replacement therapy and oral contraceptive as measured by bupropion hydroxylation |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category